A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03524092 · COMPLETED
Trial details
- NCT number
- NCT03524092
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-19
- Primary completion
- 2021-11-03
- Enrollment
- 1328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.